Eastman Chemical
622 hedge funds and large institutions have $10.9B invested in Eastman Chemical in 2017 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 224 increasing their positions, 205 reducing their positions, and 42 closing their positions.
31% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 42
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
24% more call options, than puts
Call options by funds: $99.9M | Put options by funds: $80.8M
8% more capital invested
Capital invested by funds: $10.1B → $10.9B (+$850M)
1.02% more ownership
Funds ownership: 82.48% → 83.51% (+1%)
9% more repeat investments, than reductions
Existing positions increased: 224 | Existing positions reduced: 205
1% more funds holding
Funds holding: 618 → 622 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$116M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$88.6M |
| 3 |
Millennium Management
New York
|
+$44.8M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$39.7M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$39.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$136M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$90M |
| 3 |
AIM
Atlantic Investment Management
New York
|
-$41.2M |
| 4 |
Bank of New York Mellon
New York
|
-$36.8M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$31.3M |
EMN Hedge Fund Activity: Q3 2017 in Review
622 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Eastman Chemical (EMN) for Q3 2017, worth a combined $10.9B — up 8.4% from $10.1B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new EMN positions and 42 closed out — a net gain of 13 holders — while 224 added to existing stakes and 205 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $116M. The largest seller was EdgePoint Investment Group, exiting entirely with an estimated $136M sold.
- 622 institutional investors held Eastman Chemical (EMN) as of Q3 2017, up from 618 in Q2 2017.
- Funds reported $10.9B of Eastman Chemical stock for Q3 2017, up 8.4% quarter-over-quarter.
- 55 funds opened new Eastman Chemical positions in Q3 2017 and 42 closed out, a net change of +13 holders.
- The largest Eastman Chemical buyer in Q3 2017 was T. Rowe Price Associates, an estimated $116M added.
- The largest Eastman Chemical seller in Q3 2017 was EdgePoint Investment Group, an estimated $136M sold.
Based on aggregated 13F filings for Q3 2017.